A Review Of cgmp fda
No. 21 CFR 211.113(a) requires acceptable prepared procedures to become proven and adopted through manufacturing to avoid objectionable microorganisms in drug solutions not needed to be sterile. On top of that, the 2nd paragraph of USP Common Chapter Antimicrobial Efficiency Tests reads: Antimicrobial preservatives shouldn't be applied as